Skip to main content
Equibles

CAPITAL FUND MANAGEMENT S.A.

Position in LLY — ELI LILLY & Co

CIK 1323645 PARIS, I0
Back to LLY Full portfolio

Position in LLY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$18,285,311
-$156,064,450 QoQ
Shares Held
15,245
-92.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#925
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2026
CallValue
$27,347,006
CallShares
22,800
PutValue
$42,939,597
PutShares
35,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

CAPITAL FUND MANAGEMENT S.A. holds $132,289,562 across 6 Drug Manufacturers - General names. LLY ranks #3 (13.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GILD
Gilead Sciences, Inc.
 595,241 $75,202,747
2 JNJ
Johnson & Johnson
 82,341 $20,912,143
3 LLY
ELI LILLY & Co
This page 		15,245 $18,285,311
4 ABBV
AbbVie Inc.
 47,541 $11,963,217
5 BMY
Bristol Myers Squibb Co
 77,374 $4,458,289
6 MRK
Merck & Co., Inc.
 11,423 $1,467,855

All Filings in LLY

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $42,939,597 35,800
2026-06-30 $27,347,006 22,800
2026-06-30 $18,285,311 15,245
2026-03-31 $61,992,498 67,400
2026-03-31 $174,349,761 189,558
2026-03-31 $12,048,987 13,100
2025-12-31 $81,460,751 75,800
2025-12-31 $151,637,362 141,100
2025-09-30 $78,283,800 102,600
2025-09-30 $102,470,900 134,300
2025-09-30 $21,474,635 28,145
2025-06-30 $105,392,456 135,200
2025-06-30 $84,890,817 108,900
2025-03-31 $69,376,440 84,000
2025-03-31 $67,889,802 82,200
2024-12-31 $109,855,600 142,300
2024-12-31 $14,765,272 19,126
2024-12-31 $107,308,000 139,000
2024-09-30 $107,641,710 121,500
2024-09-30 $149,635,266 168,900
2024-06-30 $173,199,194 191,300
2024-06-30 $143,412,192 158,400
2024-03-31 $182,431,620 234,500
2024-03-31 $151,313,220 194,500
2023-12-31 $100,553,700 172,500
2023-12-31 $170,212,640 292,000
2023-09-30 $52,961,018 98,600
2023-09-30 $9,097,370 16,937
2023-09-30 $82,127,177 152,900
2023-06-30 $38,550,156 82,200
2023-06-30 $36,580,440 78,000
2023-03-31 $8,870,882 25,831
2023-03-31 $32,590,558 94,900
2023-03-31 $36,230,810 105,500
2022-12-31 $13,609,248 37,200
2022-12-31 $10,878,618 29,736
2022-12-31 $11,780,048 32,200
2022-09-30 $29,748,200 92,000
2022-09-30 $30,491,905 94,300
2022-06-30 $7,295,175 22,500
2022-06-30 $8,105,750 25,000
2022-03-31 $24,570,546 85,800
2022-03-31 $8,132,908 28,400
2021-12-31 $23,644,432 85,600
2021-12-31 $44,360,932 160,600
2021-09-30 $30,660,335 132,700
2021-09-30 $19,084,730 82,600
2021-06-30 $6,380,656 27,800
2021-06-30 $20,817,464 90,700
2021-03-31 $5,249,642 28,100

Report a Problem

Category
Description
Email (optional, for follow-up)